Chemours (CC) Declares $0.25 Dividend

Chemours said on April 27, 2023 that its board of directors declared a regular quarterly dividend of $0.25 per share ($1.00 annualized). Previously, the company paid $0.25 per share.

Shares must be purchased before the ex-div date of May 12, 2023 to qualify for the dividend. Shareholders of record as of May 15, 2023 will receive the payment on June 15, 2023.

At the current share price of $29.07 / share, the stock's dividend yield is 3.44%.

Looking back five years and taking a sample every week, the average dividend yield has been 4.03%, the lowest has been 1.29%, and the highest has been 12.18%. The standard deviation of yields is 1.92 (n=236).

The current dividend yield is 0.31 standard deviations below the historical average.

Additionally, the company's dividend payout ratio is 0.30. The payout ratio tells us how much of a company's income is paid out in dividends. A payout ratio of one (1.0) means 100% of the company's income is paid in a dividend. A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Companies with few growth prospects are expected to pay out most of their income in dividends, which typically means a payout ratio between 0.5 and 1.0. Companies with good growth prospects are expected to retain some earnings in order to invest in those growth prospects, which translates to a payout ratio of zero to 0.5.

The company has not increased its dividend in the last three years.

Learn to Harvest Dividends

Buy Stock. Capture Dividend. Sell Stock. Repeat. This is the essence of dividend harvesting and you can do it easily with Fintel's Dividend Capture Calendar.

What is the Fund Sentiment?

There are 943 funds or institutions reporting positions in Chemours. This is a decrease of 6 owner(s) or 0.63% in the last quarter. Average portfolio weight of all funds dedicated to CC is 0.17%, an increase of 6.70%. Total shares owned by institutions decreased in the last three months by 2.70% to 121,431K shares. CC / Chemours Company Put/Call Ratios The put/call ratio of CC is 1.28, indicating a bearish outlook.

Analyst Price Forecast Suggests 34.04% Upside

As of April 24, 2023, the average one-year price target for Chemours is 38.96. The forecasts range from a low of 27.27 to a high of $54.60. The average price target represents an increase of 34.04% from its latest reported closing price of 29.07.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Chemours is 6,784MM, an increase of 3.32%. The projected annual non-GAAP EPS is 4.55.

What are Other Shareholders Doing?

CC / Chemours Company Shares Held by Institutions

IJH - iShares Core S&P Mid-Cap ETF holds 4,661K shares representing 3.13% ownership of the company. In it's prior filing, the firm reported owning 4,533K shares, representing an increase of 2.73%. The firm increased its portfolio allocation in CC by 11.46% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 4,597K shares representing 3.09% ownership of the company. In it's prior filing, the firm reported owning 4,624K shares, representing a decrease of 0.59%. The firm increased its portfolio allocation in CC by 14.05% over the last quarter.

DVY - iShares Select Dividend ETF holds 4,491K shares representing 3.02% ownership of the company. In it's prior filing, the firm reported owning 4,335K shares, representing an increase of 3.48%. The firm increased its portfolio allocation in CC by 20.05% over the last quarter.

NAESX - Vanguard Small-Cap Index Fund Investor Shares holds 3,888K shares representing 2.61% ownership of the company. In it's prior filing, the firm reported owning 3,939K shares, representing a decrease of 1.32%. The firm increased its portfolio allocation in CC by 13.50% over the last quarter.

Lsv Asset Management holds 2,952K shares representing 1.98% ownership of the company. In it's prior filing, the firm reported owning 3,114K shares, representing a decrease of 5.48%. The firm increased its portfolio allocation in CC by 10.54% over the last quarter.

Chemours Background Information
(This description is provided by the company.)

The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining, and general industrial manufacturing. Its flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™. In 2019, Chemours was named to Newsweek's list of America's Most Responsible Companies. The company has approximately 7,000 employees and 30 manufacturing sites serving approximately 3,700 customers in over 120 countries. Chemours is headquartered in Wilmington, Delaware.

This story originally appeared on Fintel.

Fintel
Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.
Check out our Unique Analysis of Insider Sentiment for Chemours Company Find out what the Options Markets think of Chemours Company See our take on Chemours Company Upcoming Earnings More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available